Clinical Trial Update: A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase III study evaluating MG-K10 for adolescents with moderate-to-severe atopic dermatitis; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Dermatitis, Atopic | Phase 3 | Status: NOT_YET_RECRUITING